OpenAI for Science is an initiative through which the company addresses scientists – and certainly wants to retain them. Now OpenAI is launching Prism, an AI-based workspace for scientific writing.
Boston Scientific said on Thursday it will buy medtech firm Penumbra in a deal valued at about $14.5 billion to expand its portfolio of cardiovascular devices, in the largest acquisition by the ...
Jan 15 (Reuters) - Boston Scientific said on Thursday it will buy Penumbra in a deal valued at about $14.5 billion to expand its vascular pipeline. The deal values Penumbra at $374 per share, a ...
Teledyne Technologies, Inc. TDY recently stated that it has acquired DD-Scientific Holdings Limited and its subsidiary DD-Scientific Limited, a leading developer and manufacturer of high-performance ...
Artificial intelligence promises to accelerate scientific discovery and open new frontiers of inquiry. But new research from James Evans (Faculty Co-Director of Novel Intelligence; Max Palevsky ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results